Combined and targeted drugs delivery system for colorectal cancer treatment: Conatumumab decorated, reactive oxygen species sensitive irinotecan prodrug and quercetin co-loaded nanostructured lipid carriers

References

• Alberts SR, Horvath WL, Sternfeld WC, et al. (2005). Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 23:9243–9.
   PubMed Web of Science ®Google Scholar
• Arnold M, Sierra MS, Laversanne M, et al. (2017). Global patterns and trends in colorectal cancer incidence and mortality. Gut 66:683–91.
   PubMed Web of Science ®Google Scholar
• Bavi P, Prabhakaran SE, Abubaker J, et al. (2010). Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations. Mol Cancer 9:203.
   PubMed Web of Science ®Google Scholar
• Chen W, Guo M, Wang S. (2016). Anti prostate cancer using PEGylated bombesin containing, cabazitaxel loading nano-sized drug delivery system. Drug Dev Ind Pharm 42:1968–76.
   PubMed Web of Science ®Google Scholar
• Chou TC, Talalay P. (1984). Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27–55.
   PubMedGoogle Scholar
• Chou TC. (2010). Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70:440–6.
   PubMed Web of Science ®Google Scholar
• Dong S, Zhou X, Yang J. (2016). TAT modified and lipid – PEI hybrid nanoparticles for co-delivery of docetaxel and pDNA. Biomed Pharmacother 84:954–61.
   PubMed Web of Science ®Google Scholar
• Duan W, Liu Y. (2018). Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib. Drug Des Devel Ther 12:2149–61.
   PubMed Web of Science ®Google Scholar
• Falcone A, Ricci S, Brunetti I, et al. (2007). Gruppo Oncologico Nord Ovest. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. JCO 25:1670–6.
   PubMed Web of Science ®Google Scholar
• Fang T, Dong Y, Zhang X, et al. (2016). Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors. Int J Pharm 512:39–48.
   PubMed Web of Science ®Google Scholar
• Guo S, Huang L. (2014). Nanoparticles containing insoluble drug for cancer therapy. Biotechnol Adv 32:778–88.
   PubMed Web of Science ®Google Scholar
• Hong Y, Che S, Hui B, et al. (2019). Lung cancer therapy using doxorubicin and curcumin combination: targeted prodrug based, pH sensitive nanomedicine. Biomed Pharmacother 112:108614.
   PubMed Web of Science ®Google Scholar
• Li F, Mei H, Gao Y, et al. (2017). Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer. Biomaterials 145:56–71.
   PubMed Web of Science ®Google Scholar
• Li S, Wang L, Li N, et al. (2017). Combination lung cancer chemotherapy: design of a pH-sensitive transferrin-PEG-Hz-lipid conjugate for the co-delivery of docetaxel and baicalin. Biomed Pharmacother 95:548–55.
   PubMed Web of Science ®Google Scholar
• Ling X, Zhang S, Shao P, et al. (2015). Synthesis of a reactive oxygen species responsive heterobifunctional thioketal linker. Tetrahedron Lett 56:5242–4.
   PubMed Web of Science ®Google Scholar
• Liu B, Han L, Liu J, et al. (2017). Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer. Int J Nanomedicine 12:955–68.
   PubMed Web of Science ®Google Scholar
• Liu K, Chen W, Yang T, et al. (2017). Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery. Int J Nanomedicine 12:8239–55.
   PubMed Web of Science ®Google Scholar
• Lucas AS, O'Neil BH, Goldberg RM. (2011). A decade of advances in cytotoxic chemotherapy for metastatic colorectal cancer. Clin Colorectal Cancer 10:238–44.
   PubMed Web of Science ®Google Scholar
• Lv L, Liu C, Chen C, et al. (2016). Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer. Oncotarget 7:32184–99.
   PubMedGoogle Scholar
• Mandal B, Bhattacharjee H, Mittal N, et al. (2013). Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform. Nanomedicine 9:474–91.
   PubMed Web of Science ®Google Scholar
• Masi G, Vasile E, Loupakis F, et al. (2008). Triplet combination of fluoropyrimidines, oxaliplatin, and irinotecan in the first-line treatment of metastatic colorectal cancer. Clin Colorectal Cancer 7:7–14.
   PubMed Web of Science ®Google Scholar
• Mathijssen RH, van Alphen RJ, Verweij J, et al. (2001). Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Clin Cancer Res 7:2182–94.
   PubMed Web of Science ®Google Scholar
• Nan Y. (2019). Lung carcinoma therapy using epidermal growth factor receptor-targeted lipid polymeric nanoparticles co-loaded with cisplatin and doxorubicin. Oncol Rep 42:2087–96.
   PubMed Web of Science ®Google Scholar
• Noh I, Kim HO, Choi J, et al. (2015). Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer. Biomaterials 53:763–74.
   PubMed Web of Science ®Google Scholar
• Rashedi J, Ghorbani Haghjo A, Mesgari Abbasi M, et al. (2019). Anti-tumor effect of quercetin loaded chitosan nanoparticles on induced colon cancer in Wistar rats. Adv Pharm Bull 9:409–15.
   PubMed Web of Science ®Google Scholar
• Roese E, Bunjes H. (2017). Drug release studies from lipid nanoparticles in physiological media by a new DSC method. J Control Release 256:92–100.
   PubMed Web of Science ®Google Scholar
• Ruan C, Liu L, Lu Y, et al. (2018). Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma. Acta Pharm Sin B 8:85–96.
   PubMed Web of Science ®Google Scholar
• Shao Z, Shao J, Tan B, et al. (2015). Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA. Int J Nanomedicine 10:1223–33.
   PubMed Web of Science ®Google Scholar
• Slatter JG, Su P, Sams JP, et al. (1997). Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions. Drug Metab Dispos 25:1157–64.
   PubMed Web of Science ®Google Scholar
• Tan S, Wang G. (2018). Lung cancer targeted therapy: folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin. Biomed Pharmacother 102:55–63.
   PubMed Web of Science ®Google Scholar
• Tiernan JP, Perry SL, Verghese ET, et al. (2013). Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting. Br J Cancer 108:662–7.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Nordlinger B, Adam R, et al. (2006). Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 42:2212–21.
   PubMed Web of Science ®Google Scholar
• Wang J, Sun X, Mao W, et al. (2013). Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy. Adv Mater 25:3670–6.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wei Y, Fang G, et al. (2018). Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly(ethylene glycol)-ε-poly(caprolactone) nanocarriers. Drug Des Devel Ther 12:3171–80.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zang A, Wei Y, et al. (2020). Hyaluronic acid capped, irinotecan and gene co-loaded lipid-polymer hybrid nanocarrier-based combination therapy platform for colorectal cancer. Drug Des Devel Ther 14:1095–105.
   PubMed Web of Science ®Google Scholar
• Whang CH, Yoo E, Hur SK, et al. (2018). A highly GSH-sensitive SN-38 prodrug with an "OFF-to-ON" fluorescence switch as a bifunctional anticancer agent. Chem Commun 54:9031–4.
   PubMed Web of Science ®Google Scholar
• Wu R, Zhang Z, Wang B, et al. (2020). Combination chemotherapy of lung cancer - co-delivery of docetaxel prodrug and cisplatin using aptamer-decorated lipid-polymer hybrid nanoparticles. Drug Des Devel Ther 14:2249–61. Jun 9
   PubMed Web of Science ®Google Scholar
• Xing J, Zhang X, Wang Z, et al. (2019). Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy. Int J Nanomedicine 14:5201–13.
   PubMed Web of Science ®Google Scholar
• Xu G, Shi H, Ren L, et al. (2015). Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles. Int J Nanomedicine 10:2051–63.
   PubMed Web of Science ®Google Scholar
• Yang G, Wu F, Chen M, et al. (2019). Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides. Int J Nanomedicine 14:2267–80.
   PubMed Web of Science ®Google Scholar
• Yarjanli Z, Ghaedi K, Esmaeili A, et al. (2019). The antitoxic effects of quercetin and quercetin-conjugated iron oxide nanoparticles (QNPs) against H2O2-induced toxicity in PC12 cells. Int J Nanomedicine 14:6813–30.
   PubMed Web of Science ®Google Scholar
• Yuan M, Qiu Y, Zhang L, et al. (2016). Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma. Drug Deliv 23:1171–83.
   PubMed Web of Science ®Google Scholar
• Zhang J, Shen L, Li X, et al. (2019). Nanoformulated codelivery of quercetin and alantolactone promotes an antitumor response through synergistic immunogenic cell death for microsatellite-stable colorectal cancer. ACS Nano 13:12511–24.
   PubMed Web of Science ®Google Scholar
• Zhang J, Xiao X, Zhu J, et al. (2018). Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy. Int J Nanomedicine 13:3039–51.
   PubMed Web of Science ®Google Scholar
• Zhang R, Ru Y, Gao Y, et al. (2017). Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer. Drug Des Devel Ther 11:2631–42.
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang J, Pan J. (2016). Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Drug Deliv 23:3696–703.
   PubMed Web of Science ®Google Scholar
• Zhu B, Yu L, Yue Q. (2017). Co-delivery of vincristine and quercetin by nanocarriers for lymphoma combination chemotherapy. Biomed Pharmacother 91:287–94.
   PubMed Web of Science ®Google Scholar